Market capitalization | SEK61.66b |
Enterprise Value | SEK68.22b |
P/E (TTM) P/E ratio | 23.86 |
EV/FCF (TTM) EV/FCF | 20.80 |
EV/Sales (TTM) EV/Sales | 2.05 |
P/S ratio (TTM) P/S ratio | 1.85 |
P/B ratio (TTM) P/B ratio | 1.96 |
Dividend yield | 1.94% |
Last dividend (FY23) | SEK4.40 |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
12 Analysts have issued a Getinge forecast:
12 Analysts have issued a Getinge forecast:
Dec '23 |
+/-
%
|
||
Net Profit | 2,412 2,412 |
3%
3%
|
|
Depreciation and Amortization | 2,093 2,093 |
3%
3%
|
|
Stock Compensation | - - |
-
|
|
Operating Cash Flow | 2,957 2,957 |
12%
12%
|
|
Investments | 1,353 1,353 |
19%
19%
|
|
Dividend Paid | 1,158 1,158 |
6%
6%
|
|
Free Cash Flow | 1,604 1,604 |
28%
28%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It engages in supplying of solutions for theaters, intensive care units, sterilization centers and companies and institutions within life science. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.
Head office | Sweden |
CEO | Mattias Perjos |
Employees | 11,739 |
Founded | 1990 |
Website | www.getinge.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.